Woodline Partners’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $553K | Buy |
+142,863
| New | +$553K | ﹤0.01% | 848 |
|
|
2024
Q2 | – | Sell |
-214,245
| Closed | -$2.18M | – | 553 |
|
|
2024
Q1 | $2.18M | Buy |
+214,245
| New | +$2.18M | 0.02% | 420 |
|
|
2023
Q1 | – | Sell |
-1,304,024
| Closed | -$21.5M | – | 626 |
|
|
2022
Q4 | $21.5M | Buy |
1,304,024
+285,933
| +28% | +$4.7M | 0.29% | 94 |
|
|
2022
Q3 | $13M | Buy |
1,018,091
+467,406
| +85% | +$5.97M | 0.18% | 161 |
|
|
2022
Q2 | $6.44M | Sell |
550,685
-295,933
| -35% | -$3.46M | 0.1% | 221 |
|
|
2022
Q1 | $5.16M | Buy |
846,618
+225,940
| +36% | +$1.38M | 0.08% | 239 |
|
|
2021
Q4 | $5.69M | Buy |
620,678
+271,855
| +78% | +$2.49M | 0.08% | 268 |
|
|
2021
Q3 | $3.95M | Buy |
+348,823
| New | +$3.95M | 0.06% | 292 |
|